midazolam has been researched along with Spinal Cord Diseases in 1 studies
Midazolam: A short-acting hypnotic-sedative drug with anxiolytic and amnestic properties. It is used in dentistry, cardiac surgery, endoscopic procedures, as preanesthetic medication, and as an adjunct to local anesthesia. The short duration and cardiorespiratory stability makes it useful in poor-risk, elderly, and cardiac patients. It is water-soluble at pH less than 4 and lipid-soluble at physiological pH.
midazolam : An imidazobenzodiazepine that is 4H-imidazo[1,5-a][1,4]benzodiazepine which is substituted by a methyl, 2-fluorophenyl and chloro groups at positions 1, 6 and 8, respectively.
Spinal Cord Diseases: Pathologic conditions which feature SPINAL CORD damage or dysfunction, including disorders involving the meninges and perimeningeal spaces surrounding the spinal cord. Traumatic injuries, vascular diseases, infections, and inflammatory/autoimmune processes may affect the spinal cord.
Excerpt | Relevance | Reference |
---|---|---|
"Life-threatening myoclonus developed in a patient following inadvertent intrathecal usage of 60% diatrizoate meglumine." | 1.29 | Spinal myoclonus following intrathecal administration of diatrizoate meglumine. ( Gutmann, L; Sam, MC, 1996) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Sam, MC | 1 |
Gutmann, L | 1 |
1 other study available for midazolam and Spinal Cord Diseases
Article | Year |
---|---|
Spinal myoclonus following intrathecal administration of diatrizoate meglumine.
Topics: Aged; Contrast Media; Diatrizoate Meglumine; Humans; Hypnotics and Sedatives; Injections, Spinal; Ma | 1996 |